2021
DOI: 10.1542/peds.2021-053427
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 Vaccination–Associated Myocarditis in Adolescents

Abstract: This is a prepublication version of an article that has undergone peer review and been accepted for publication but is not the final version of record. This paper may be cited using the DOI and date of access. This paper may contain information that has errors in facts, figures, and statements, and will be corrected in the final published version. The journal is providing an early version of this article to expedite access to this information. The American Academy of Pediatrics, the editors, and authors are no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

10
126
2
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 106 publications
(140 citation statements)
references
References 33 publications
(63 reference statements)
10
126
2
1
Order By: Relevance
“…Multisystem inflammatory syndrome (MIS) in children (MIS‐C) is a complication of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, while myocarditis is a rare adverse effect to messenger ribonucleic acid (mRNA) SARS‐CoV‐2 vaccines, especially in males aged 12–17 years. 1 , 2 As far as we are aware, no cases of MIS‐C after mRNA SARS‐CoV‐2 vaccinations have been reported in children or adolescents. However, 1 case of MIS after the Pfizer‐BioNTech mRNA vaccine has been described in a 44‐year‐old woman without a previous SARS‐CoV‐2 infection.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Multisystem inflammatory syndrome (MIS) in children (MIS‐C) is a complication of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, while myocarditis is a rare adverse effect to messenger ribonucleic acid (mRNA) SARS‐CoV‐2 vaccines, especially in males aged 12–17 years. 1 , 2 As far as we are aware, no cases of MIS‐C after mRNA SARS‐CoV‐2 vaccinations have been reported in children or adolescents. However, 1 case of MIS after the Pfizer‐BioNTech mRNA vaccine has been described in a 44‐year‐old woman without a previous SARS‐CoV‐2 infection.…”
mentioning
confidence: 99%
“…In addition, myocarditis, often accompanied by fever and myalgia, is a rare adverse effect of mRNA vaccines. 1 , 2 Furthermore, myocarditis occurs more frequently in male adolescents after the second vaccine. 1 , 2 This was in accordance with our male adolescent developing MIS‐C with myocarditis a few days after the second vaccination.…”
mentioning
confidence: 99%
“…All of them showed troponin I elevation and LGE in the CMR, with a complete recovery [119]. In the same way, Jain et al reported that myocarditis after mRNA vaccines evolved mainly with mild symptoms in 63 adolescent patients, with the resolution of the clinical manifestations at a mean of 35 days [120]. Additional follow-up will probably be needed to determine the actual incidence and prognosis of vaccine-related myocarditis in the general population.…”
Section: Covid-19 Vaccine Side Effectsmentioning
confidence: 80%
“…Tatsächlich sind Peri- und Myokarditiden als Impfnebenwirkung erst im Kontext der breiten Anwendung der mRNA-Impfstoffe aufgefallen. Die klinischen Verläufe der besonders bei jungen Männern auftretenden Myo- und Perikarditiden sind bisher unkompliziert gewesen; Todesfälle wurden nicht berichtet [ 52 ]. Es fehlen allerdings Daten zum Langzeitverlauf, z.…”
Section: Covid‑19-impfungunclassified